SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD
Cell Reports, ISSN: 2211-1247, Vol: 42, Issue: 1, Page: 111961
2023
- 2Citations
- 11Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- CrossRef2
- Captures11
- Readers11
- 11
- Mentions1
- News Mentions1
- News1
Most Recent News
Research Conducted at Albert-Ludwigs-University Has Provided New Information about Biology (Article Spata2 Restricts Otulin-dependent Lubac Activity Independently of Cyld)
2023 MAR 22 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Life Science Daily -- Researchers detail new data in Life Sciences -
Article Description
SPATA2 mediates the recruitment of CYLD to immune receptor complexes by bridging the interaction of CYLD with the linear ubiquitylation assembly complex (LUBAC) component HOIP. Whether SPATA2 exhibits functions independently of CYLD is unclear. Here, we show that, while Cyld −/− and Spata2 −/− mice are viable, double mutants exhibit highly penetrant perinatal lethality, indicating independent functions of SPATA2 and CYLD. Cyld −/− Spata2 −/− fibroblasts show increased M1-linked TNFR1-SC ubiquitylation and, similar to Cyld −/− Spata2 −/− macrophages and intestinal epithelial cells, elevated pro-inflammatory gene expression compared with Cyld −/− or Spata2 −/− cells. We show that SPATA2 competes with OTULIN for binding to HOIP via its PUB-interacting motif (PIM) and its zinc finger domain, thereby promoting autoubiquitylation of LUBAC. Consistently, increased pro-inflammatory signaling in Cyld −/− Spata2 −/− cells depends on the presence of OTULIN. Our data therefore indicate that SPATA2 counteracts, independently of CYLD, the deubiquitylation of LUBAC by OTULIN and thereby attenuates LUBAC activity and pro-inflammatory signaling.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211124722018654; http://dx.doi.org/10.1016/j.celrep.2022.111961; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85147102946&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36640323; https://linkinghub.elsevier.com/retrieve/pii/S2211124722018654; https://dx.doi.org/10.1016/j.celrep.2022.111961
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know